Next Article in Journal
Briarane Diterpenoids from the Gorgonian Dichotella gemmacea
Next Article in Special Issue
Synthesis of Enantiopure Reversed Structured Ether Lipids of the 1-O-Alkyl-sn-2,3-diacylglycerol Type
Previous Article in Journal
Astaxanthin Activates Nuclear Factor Erythroid-Related Factor 2 and the Antioxidant Responsive Element (Nrf2-ARE) Pathway in the Brain after Subarachnoid Hemorrhage in Rats and Attenuates Early Brain Injury
Previous Article in Special Issue
Synthetic Strategies to Terpene Quinones/Hydroquinones
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Marine Drugs
Volume 12
Issue 12
10.3390/md12126142
marinedrugs-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Synthetic Approaches to the Lamellarins—A Comprehensive Review

by
Dennis Imbri
,
Johannes Tauber
and
Till Opatz
*
Institute of Organic Chemistry, Johannes Gutenberg-University Mainz, Duesbergweg 10-14, 55128 Mainz, Germany
*
Author to whom correspondence should be addressed.
Mar. Drugs 2014, 12(12), 6142-6177; https://doi.org/10.3390/md12126142
Submission received: 3 November 2014 / Revised: 1 December 2014 / Accepted: 5 December 2014 / Published: 18 December 2014
(This article belongs to the Special Issue Synthesis around Marine Natural Products)
Browse Figures
Versions Notes

Abstract

:
The present review discusses the known synthetic routes to the lamellarin alkaloids published until 2014. It begins with syntheses of the structurally simpler type-II lamellarins and then focuses on the larger class of the 5,6-saturated and -unsaturated type-I lamellarins. The syntheses are grouped by the strategy employed for the assembly of the central pyrrole ring.

Graphical Abstract

1. Introduction

The Lamellarins were first isolated by Faulkner and co-workers in 1985 from the prosobranch mollusc Lamellaria sp. [1,2,3,4,5,6,7,8,9,10,11] and represent a group of more than 50 polycyclic marine alkaloids which contain a central pyrrole moiety. The pyrrole ring may be part of a fused pentacyclic skeleton of the 6H-chromeno[4′,3′:4,5]pyrrolo[2,1-a]isoquinolin-6-one type possessing a partially saturated (type Ia) or fully unsaturated (type Ib) isoquinoline moiety [12,13,14,15]. Furthermore, structurally simpler representatives of the lamellarins containing a 3,4-diaryl substituted pyrrole core (type II) are known (Figure 1) [4,5]. Their substitution in terms of a varying oxygenation and O-substitution pattern provides the basis for their structural diversity as well as for notable differences in their biological activity.
Marinedrugs 12 06142 g001 1024
Figure 1. Structure of lamellarins type Ia, Ib and II [16].
Figure 1. Structure of lamellarins type Ia, Ib and II [16].
Marinedrugs 12 06142 g001
Many lamellarins were found to exhibit significant biological effects on mammalian cells or even viruses, such as antiproliferative and multidrug resistance reversal activity, cytotoxicity, or the inhibition of HIV-1 integrase [17,18,19,20,21,22,23]. Structure activity relationships were investigated with a particular emphasis on lamellarin D, the most cytotoxic representative of the lamellarins [24,25,26,27,28]. These studies resulted in a pharmacophore model explaining the structural features required for inhibiting the action of eukaryotic topoisomerase I, an enzyme required for transcription and replication of DNA [29,30,31,32,33,34,35,36]. In order to provide samples of the natural lamellarins or their synthetic derivatives for biomedical research [37,38,39,40,41], various synthetic strategies have been developed. While synthetic, biological and biomedical as well as biophysical aspects of the lamellarins have already been the subject of various reviews [42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64], we herein present an overview of all synthetic approaches published until today (2014). The syntheses are grouped by the class of the lamellarin synthesized (type II vs. type Ia/Ib) as well as by the strategy used for the construction and/or decoration of the central pyrrole ring.

2. Syntheses of type-II Lamellarins

2.1. Fürstner 1995 [65]

A decade after the discovery of the lamellarins [1] Fürstner and co-workers reported in 1995 the first total synthesis of a type-II lamellarin [65] characterized by a non-fused pyrrole moiety. In his approach to lukinaol A (6), lamellarin O dimethyl ether (5) was used as an intermediate. The route started with a Scheffer-Weitz-epoxidation of enone 1 followed by Lewis acid-mediated rearrangement and condensation with hydroxylamine to afford isoxazole 2. Upon reductive cleavage of the N-O bond, condensation with methyl oxalyl chloride and McMurry-type cyclization with Ti-graphite, the 3,4,5‑trisubstituted pyrrole was formed which readily yielded lamellarin O dimethyl ether (5) upon N‑alkylation with 2-bromo-4′-methoxyacetophenone (4) in 21% over six steps (Scheme 1).
This and any further mentioned yields as well as the numbers of synthetic steps given in this review will, if not stated otherwise, refer to the respective data of the longest linear sequence as provided by the authors themselves. In case of convergent syntheses with a shorter but lower-yielding branch, the overall yield stated refers to the yield-limiting sequence.
Marinedrugs 12 06142 g002 1024
Scheme 1. Synthesis of lamellarin O dimethyl ether by Fürstner et al. [65].
Scheme 1. Synthesis of lamellarin O dimethyl ether by Fürstner et al. [65].
Marinedrugs 12 06142 g002

2.2. Banwell 1997 [66]

Cross-couplings such as Stille, Suzuki or Negishi reactions served as the key steps in the synthesis of lamellarin O, lamellarin Q and lukianol A by Banwell and co-workers. The TIPS-protected pyrrole 7 was tribrominated with three equivalents of N-bromosuccinimide to form the tribromo derivative which was subjected to halogen-lithium exchange with phenyllithium followed by quenching with methyl chloroformate to afford dibromopyrrole 2-carboxylate 8. Lamellarin Q (10) was then synthesized by twofold Stille cross-coupling with aryl stannane 9 and subsequent desilylation with Bu4NF in 58% over four steps starting from 7. To prevent O-alkylation, the synthesis of lamellarin O was initiated with an N-desilylation followed by twofold Stille cross-coupling with aryl stannane 9. The coupling product 11 was subjected to N-alkylation with 2-bromo-4′-methoxyacetophenone (4) followed by desilylation with Bu4NF to provide lamellarin O (12) in 45% over six steps. The authors reported that no significant quantities of mono-arylated pyrroles were formed even in the case of shorter reaction times or equimolar amounts of the coupling partner. Hence, differentially diarylated pyrroles were not readily accessible by this approach (Scheme 2).
Banwell and co-workers demonstrated a method to overcome this limitation by regioselective halogen-lithium exchange and subsequent transmetallation into an organozinc derivative, thus allowing the differentiation between positions 3 and 4 in the pyrrole unit.

2.3. Boger 1999 [67]

An azadiene Diels-Alder strategy, namely a 1,2,4,5-tetrazine-1,2-diazine-pyrrole transformation sequence, was used by Boger and co-workers for the construction of the lamellarin framework. The pyrrole moiety was thus assembled by a [4+2] cycloaddition/cycloreversion reaction followed by a reductive ring transformation, a method infrequently used for the construction of five membered heteroaromatic systems. Starting from benzyl protected aryl acetylene 13 and aryl iodide 14, the acetylenic precursor 15 was prepared by Sonogashira-coupling. The undesired homocoupling of the alkyne component was suppressed by its slow addition to a solution of the iodide 14. Cycloaddition/cycloreversion of tolan 15 to 1,2,4,5-tetrazine 16 gave 1,2-diazine 17 which was subjected to zinc-mediated reductive ring contraction followed by N-alkylation with 2-bromo-4′-methoxyacetophenone (4). Selective hydrolysis of the symmetrical diester 18 with lithium hydroxide provided the monoacid 19 which was decarboxylated in the presence of an excess of trifluoroacetic acid. Subsequent hydrogenolysis afforded lamellarin O (12) in 34% overall yield over seven steps (Scheme 3).
Marinedrugs 12 06142 g003 1024
Scheme 2. Synthesis of lamellarins O and Q by Banwell et al. [66].
Scheme 2. Synthesis of lamellarins O and Q by Banwell et al. [66].
Marinedrugs 12 06142 g003
Marinedrugs 12 06142 g004 1024
Scheme 3. Synthesis of lamellarin O by Boger et al. [67].
Scheme 3. Synthesis of lamellarin O by Boger et al. [67].
Marinedrugs 12 06142 g004

2.4. Álvarez 2004 [68]

A solid phase synthesis of lamellarin Q and O was reported by Álvarez and co-workers. They employed a variation of Banwell’s route of 1997 (vide supra) [66] which was adapted to the requirements of solid phase organic chemistry. Different strategies of linking the central pyrrole unit to the resin were investigated while linking through the nitrogen was ruled out due to the lacking flexibility in introducing diversity at this position.
The resin-bound pyrrole 23 was obtained by Negishi cross-coupling of the highly functionalized organozinc reagent 22, the preparation and utility of which had been demonstrated earlier by Banwell, with the resin-bound iodophenol 21. A quantitative coupling yield was ensured by using a tenfold excess of the haloarene. Two possible routes, either with the zinc attached to the immobilized reactant or to the soluble coupling partner, were taken into account. While the zinc derivative of resin-bound pyrrole failed to meet the expectations, Suzuki-Miyaura cross-coupling reaction of 23 with boronic acid 24 provided the corresponding diarylpyrrole 25. Treatment with AlCl3 induced a simultaneous N‑ and O-deprotection as well as the cleavage from the resin, yielding lamellarin Q (10) in 13% yield. On the other hand, N-desilylation with NH4F followed by N-alkylation of 26 with 2‑bromo‑4′‑methoxyacetophenone (4) and subsequent O-deprotection/cleavage with AlCl3 provided lamellarins O (12) and Q (10) as a mixture which proved to be impossible to separate by HPLC (Scheme 4).
Marinedrugs 12 06142 g005 1024
Scheme 4. Synthesis of lamellarins O and Q by Álvarez et al. [68].
Scheme 4. Synthesis of lamellarins O and Q by Álvarez et al. [68].
Marinedrugs 12 06142 g005

2.5. Iwao 2008 [69]

The Suzuki-Miyaura cross-coupling approach used by Banwell in 1997 (vide supra) [66] was refined by Iwao and co-workers in the synthesis of lamellarins O, P, Q, and R. Therefore, N‑benzenesulfonyl-3,4-dibromopyrrole (28) was subjected to twofold Suzuki-Miyaura cross-coupling providing the diarylpyrrole 29. The dibromopyrrole intermediate 28 is readily available from pyrrole (27) by sulfonylation and bromination with Br2 in acetic acid in 28% over two steps. The kinetically disfavored β‑bromination becomes practicable under thermodynamic conditions in acidic medium. In contrast to the Banwell route, the ester moiety was introduced on a later stage by lithiating diarylpyrrole 29 with LDA and subsequent quenching with methyl chloroformate. Upon N‑deprotection with Bu4NF, pyrrole 30 was obtained which was further deprotected with BCl3 (Iwao had demonstrated already in his synthesis of 2005 that BCl3 is a selective reagent for the cleavage of benzyl or isopropyl ethers in lamellarin precursors without affecting methyl ethers, which on the other hand are easily removed by BBr3—vide infra) to afford lamellarin Q (10) in 7% over seven steps (25% from dibromopyrrole 28). N-Alkylation of 30 with the corresponding bromide 31 followed by cleavage of the isopropyl ethers with BCl3 afforded lamellarin O (12) and P (32) in 11% and 12% over eight steps, respectively (40% and 43% from 28). Lamellarin R (33) was synthesized by a Chan-Lam-Evans-type N-arylation of 30 followed by O-deprotection with BCl3 in 8% over eight steps (29% from 28, Scheme 5).
Marinedrugs 12 06142 g006 1024
Scheme 5. Synthesis of lamellarins O, P, Q and R by Iwao et al. [69].
Scheme 5. Synthesis of lamellarins O, P, Q and R by Iwao et al. [69].
Marinedrugs 12 06142 g006

2.6. Jia 2011 [70]

Keeping the structural properties of the lamellarins in mind and considering the differences between type I and type II lamellarins, it appears reasonable to assume that the type II structures precede those of type I in the biosynthesis. In this context, Jia and co-workers reported a biomimetic approach comprising three oxidative ring closures, reactions that are commonly seen in biosynthetic pathways towards densely functionalized secondary metabolites.
Starting from p-methoxyphenylacetaldehyde (34) and p-anisidine (35), AgOAc-mediated oxidative coupling afforded pyrrole 36 in the key step of Jia’s elegant synthesis. Vilsmeier-Haack formylation followed by Pinnick/Lindgren oxidation (under the optimized conditions discussed in 5.4) provided carboxylic acid 37 which was methylated with TMSCHN2 to afford lamellarin R (33) after a threefold O-demethylation with BBr3 in 53% over five steps (Scheme 6).
Marinedrugs 12 06142 g007 1024
Scheme 6. Synthesis of lamellarin R by Jia et al. [70].
Scheme 6. Synthesis of lamellarin R by Jia et al. [70].
Marinedrugs 12 06142 g007

2.7. Vazquez 2012 [71]

The Paal-Knorr pyrrole synthesis has been chosen by Vazquez and co-workers as an alternative key step for their synthesis of lamellarins O (12) and Q (10). Here, a 2,3-diarylsuccinonitrile was used as a 1,4-dicarbonyl analogue. The approach is based on the Knoevenagel condensation between aldehyde 38 and arylacetonitrile 39 followed by conjugate addition of cyanide to the resulting cyanostilbene. Upon reduction with DIBAL-H the dialdehyde was formed in situ and cyclized to the diarylpyrrole 40 under slightly acidic pH by addition of sodium dihydrogen phosphate. Introduction of the ester moiety by trichloroacetyl chloride failed. However, addition of Steglich’s 4-dimethylaminopyridine circumvented this problem. The methyl ester 41 resulted from methanolysis of the trichloroacetylated compound. Direct hydrogenolysis of the benzyl ethers afforded lamellarin Q (10) in 28% over six steps, whereas preliminary N-alkylation with 2-bromo-4′-methoxyacetophenone (4) followed by hydrogenolysis provided lamellarin O (12) in 25% over seven steps. The use of benzyl ethers remediated the need for strong Lewis-acids for O-protection (Scheme 7).
Marinedrugs 12 06142 g008 1024
Scheme 7. Synthesis of lamellarins O and Q by Vazquez et al. [71].
Scheme 7. Synthesis of lamellarins O and Q by Vazquez et al. [71].
Marinedrugs 12 06142 g008

3. Syntheses of Type I-Lamellarins—Approaches via Halogenation and Cross-Coupling Reactions

3.1. Iwao 2003 (lamellarin G trimethyl ether) [72]-2006 (lamellarin D, L and N) [73]-2006 (lamellarin α 20‑sulfate) [74]-2010 (lamellarin α 20-sulfate, α 13-sulfate and α 13,20-disulfate) [75]

The strategy of using cross-coupling reactions to form the diarylpyrrole moiety for type II lamellarins was further investigated by Iwao and co-workers to allow the synthesis of the more complex type I-lamellarins. Commonly, lamellarin G trimethyl ether serves as a benchmark compound for comparing the efficiency of syntheses of the lamellarins as it obviates any protecting group chemistry and lacks the structural differentiation of the E- and F-ring precursor.
For lamellarin G trimethyl ether (48), the synthesis started with commercially available homoveratrylamine (42). N-dialkylation with methyl bromoacetate followed by Hinsberg pyrrole cyclization with dimethyl oxalate provided the pentasubstituted pyrrole 43 (Scheme 8). Suzuki-Miyaura cross-coupling of the bistriflate derived from 43 to an arylboronic acid 44 (2.2 to 3.0 equiv.) afforded the diarylated pyrrole, whereas a stoichiometric amount of the arylboronic acid 44 primarily produced the monoarylated pyrrole 45. Therefore, the sequential introduction of different arylboronic acids was feasible, a necessity for the formation of type I-lamellarins with respect to the regioselective construction of the D-ring lactone, i.e., the discrimination of the rings E and F. Thus, one of the arylboronic acids (46) incorporated a MOM-protected phenolic function in ortho position to achieve lactonization upon acidic deprotection. To a small extent, lactone 47 was already formed as a by-product of the cross-coupling reaction. Saponification of the second methyl ester followed by Cu2O-catalyzed decarboxylation afforded the per-O-methylated ningalin B. Formation of the dihydroisoquinoline moiety (AB unit) was effected with a hypervalent iodine reagent under Kita’s biaryl coupling conditions (PIFA/BF3∙Et2O) [76]. Lamellarin G trimethyl ether (48) was obtained in 12% yield over nine steps.
The synthesis could be shortened by applying a Pd(II)‑mediated decarboxylative cyclization on monoacid 47, a method inspired by the Pd(0)‑mediated decarboxylative cyclization of the analogous bromoacid 159 described by Steglich and co-workers in a previous article [77]. In this case, lamellarin G trimethyl ether (48) was obtained in 10% yield over eight steps. The ring closure via the Pd(II) salt proceeded regioselectively, presumably due to steric hindrance. As a side reaction, the unproductive decarboxylation of the pyrrole was observed (12%).
In contrast, predefining the hydroxy-methoxy-substitution pattern of the A-subunit, as found in lamellarins D (57), L (55) and N (58), was achieved by their introduction as a 3,4-dialkoxy-substituted aryl aldehyde. Starting from isopropyl-protected isovanillin, a sequence comprising nitroaldol condensation with CH3NO2, LiAlH4-reduction, N-dialkylation with methyl bromoacetate and Hinsberg pyrrole cyclization with dimethyl oxalate provided the common pentasubstituted pyrrole 49 (Scheme 9). Double O-triflylation with Tf2O furnished the pivotal bistriflate 50 in 32% over five steps.
Marinedrugs 12 06142 g009 1024
Scheme 8. Synthesis of lamellarin G trimethyl ether by Iwao et al. [72].
Scheme 8. Synthesis of lamellarin G trimethyl ether by Iwao et al. [72].
Marinedrugs 12 06142 g009
Along these lines, the target compounds were obtained in total yields of 18% (lamellarin D, 12 steps), 19% (lamellarin L, 11 steps) and 16% (lamellarin N, 12 steps), respectively. Similar results as for the synthesis of lamellarin G trimethyl ether (48) were encountered in the alternative construction of the AB-subunit by Pd(II)‑mediated decarboxylative cyclization with slightly lower yields (14%, 14%, and 12%, respectively) and the concomitant formation of the decarboxylated by-products (14% for lamellarin D-precursor, 15% for lamellarin N-precursor, Scheme 9).
In 2006, Iwao and co-workers extended their protocol by employing differentially protected aryl subunits E and F (isopropyl ether on F, benzyl ether on E) to obtain the selectively mono-protected pyrrole 60 in 32% over eleven steps, starting from homoveratrylamine (42). Thereby, diverse sulfated lamellarins should be available for structure-activity relationship studies. Treatment with trichloroethyl chlorosulfate followed by isopropyl ether cleavage with BCl3 provided the trichloroethyl sulfate. Finally, reductive deprotection with Zn/ammonium formate and subsequent ion exchange (Amberlite IRC-50, Na+-form) gave lamellarin α 20-sulfate (61) in 24% over 14 steps (Scheme 10). Analogously, lamellarin α 13-sulfate (67) and lamellarin α 13,20-disulfate (68) were successfully synthesized from common differentially protected intermediate 66 by Iwao’s group in 5%, 6% and 9% yield over 15, 15, and 14 steps, respectively (starting from 42). In contrast to their previous work, MOM-protection instead of the isopropyl ethers was used in combination with a different order of the Suzuki cross‑couplings and closure of the lactone ring prior to the second arylation (Scheme 11).
Marinedrugs 12 06142 g010 1024
Scheme 9. Synthesis of lamellarins D, N and L by Iwao et al. [73].
Scheme 9. Synthesis of lamellarins D, N and L by Iwao et al. [73].
Marinedrugs 12 06142 g010
Marinedrugs 12 06142 g011 1024
Scheme 10. Synthesis of lamellarin α 20-sulfate by Iwao et al. [74].
Scheme 10. Synthesis of lamellarin α 20-sulfate by Iwao et al. [74].
Marinedrugs 12 06142 g011
Marinedrugs 12 06142 g012 1024
Scheme 11. Synthesis of lamellarins α 13-sulfate, α 20-sulfate and α 13,20-disulfate by Iwao et al. [75].
Scheme 11. Synthesis of lamellarins α 13-sulfate, α 20-sulfate and α 13,20-disulfate by Iwao et al. [75].
Marinedrugs 12 06142 g012

3.2. Handy 2004 [78]

The first total synthesis of type I-lamellarins starting from pyrrole itself was reported by Handy and co-workers in 2004. A triply iterative halogenation/cross-coupling reaction sequence was applied in a regioselective fashion to obtain lamellarin G trimethyl ether as the benchmark compound for a modular synthesis of natural lamellarins.
Initially, bromopyrrole ester 69 (prepared in three steps from pyrrole, no yield stated) was N-protected with a Boc-group prior to Suzuki-Miyaura coupling with 3,4-dimethoxyphenylboronic acid to avoid extensive dehalogenation. A modest excess (2–3 equiv.) of the boronic acid was required to achieve full conversion. Regioselective bromination with NBS at the more reactive 5-position of pyrrole 70 followed by a second Suzuki coupling with arylboronic acid 71 provided pyrrole 72, while no protection of the free hydroxyl group was necessary. The dihydroisoquinoline moiety was established by O-tosylation of the primary alcohol and subsequent intramolecular N-alkylation. A final bromination followed by a third Suzuki coupling with arylboronic acid 74 and simultaneous lactonization afforded lamellarin G trimethyl ether (48) in 10% over eight steps starting from pyrrole 69. It is noteworthy that the final cross-coupling required extensive optimization due to low initial yields, and an improvement from 8% to 46% in that particular step could be achieved although a large excess of boronic acid was necessary (8 equiv.) and the main product (51%) still was the dehalogenated compound 73 (Scheme 12).
Marinedrugs 12 06142 g013 1024
Scheme 12. Synthesis of lamellarin G trimethyl ether by Handy et al. [78].
Scheme 12. Synthesis of lamellarin G trimethyl ether by Handy et al. [78].
Marinedrugs 12 06142 g013

3.3. Álvarez 2005 [79]

Lamellarin D was synthesized by Álvarez and co-workers starting from pyrrole ester 75 (available in two steps from pyrrole itself), thus presenting a generally applicable synthesis for other lamellarins, as lamellarin D already requires a regiodifferentiation strategy due to its unsymmetrical hydroxy/methoxy substitution pattern.
The AB subunit of the lamellarins was established by N-alkylation of pyrrole ester 75 with tosylate 76 which itself was prepared in a six step reaction sequence including Baeyer-Villiger oxidation, O-isopropylation, bromination, Wittig homologation, reduction and O-tosylation in 27% overall yield. Palladium-catalyzed Heck-type cyclization followed by a regioselective bromination provided tricyclic building block 77 which was subjected to Suzuki-Miyaura cross-coupling, subsequent O-isopropylation of the phenolic group and a second bromination-Suzuki cross-coupling sequence, as already described by Handy and co-workers [78]. The introduction of the aryl unit requires a large excess of boronic acid 80, presumably due to its steric hindrance. Introduction of the 5,6-double bond was accomplished by DDQ oxidation. Finally, cleavage of the isopropyl ethers with AlCl3 followed by acidic lactonization afforded lamellarin D (57) in 3% over 16 steps (Scheme 13).
Marinedrugs 12 06142 g014 1024
Scheme 13. Synthesis of lamellarin D by Álvarez et al. [79].
Scheme 13. Synthesis of lamellarin D by Álvarez et al. [79].
Marinedrugs 12 06142 g014

3.4. Banwell 2011 [80]

An entirely modular approach to the type I-lamellarins was reported by Banwell and co-workers. It consists of the successive attachment of prefunctionalized aryl units to the pyrrole moiety via Suzuki‑Miyaura cross-couplings and a decarboxylative Heck reaction to close the B-ring.
The construction of the regioselectively functionalized pyrrole 84 started from Boc-protected pyrrole 82 with a double bromination at C2 and C5, double halogen-lithium exchange and quenching with methyl chloroformate to afford diester 83. Treatment of 83 with N-iodosuccinimide (2 equiv.) followed by zinc promoted desymmetrization provided iodopyrrole 84 which was subjected to Suzuki coupling with ortho-hydroxy boronate ester 85, simultaneously forming the lactone subunit as already encountered in Iwao’s approach [72]. Thereafter, bromination with N-bromosuccinimide followed by N-alkylation under Mitsunobu conditions and Suzuki coupling with the corresponding boronate ester afforded pyrrole 88. Saponification and treatment with p-toluenesulfonic acid gave the fused pyrrole carboxylate which underwent palladium-mediated cyclization under decarboxylation.
Accordingly, lamellarin G trimethyl ether (48) was obtained in 3% over 10 steps and general applicability was shown with the first total synthesis of lamellarin S (90) in 7% over 11 steps from 3,4‑diisopropoxybenzaldehyde. In the latter case, the isopropyl ethers were cleaved following the commonly used BCl3 protocol (Scheme 14).
Marinedrugs 12 06142 g015 1024
Scheme 14. Synthesis of lamellarin G trimethyl ether and lamellarin S by Banwell et al. [80].
Scheme 14. Synthesis of lamellarin G trimethyl ether and lamellarin S by Banwell et al. [80].
Marinedrugs 12 06142 g015

3.5. Iwao 2014 [81]

Iwao and co-workers recently developed a slightly different route from dibromopyrrole 91, the intermediate also used in Banwell’s previously described strategy (vide supra) [80]. Instead of converting both bromine substituents into methoxycarbonyl units, the authors chose to convert only one, and attached the A-ring at an early stage, a connection done at a much later stage by Banwell and co-workers who attached the A-ring by closing the B-ring in the ultimate step (except deprotections). Suzuki-Miyaura cross-coupling with boronic acid 92 affords arylated pyrrole 93. Bromination of 93 proceeded regioselectively as in the synthesis of Álvarez [79]. Suzuki coupling, final bromination at the remaining position of the pyrrole ring, followed by another Suzuki coupling (each with a different arylboronic acid) yielded the lactone precursor 97. Acidic removal of the MOM group resulted in closure of the lactone ring. Two possible pathways for annulation of the B-ring via initial N-alkylation were attempted, with 2-bromoethyl phenyl sulfide (Pummerer route) or bromoacetaldehyde dimethyl acetal as two-carbon homologation agents. N-alkylation of the lactone with 2-bromoethyl phenyl sulfide followed by oxidation and TMSOTf mediated Pummerer cyclization (Craig-modification) provided phenylthio-lamellarin 99, whereas the application of standard reaction conditions (excess of triflic anhydride) mainly led to the reduced precursor. Radical desulfurization of 99 with Bu3SnH/AIBN provided access to saturated lamellarins (type Ia), whereas oxidation with m-CPBA followed by elimination of the intermediate sulfoxide generated unsaturated lamellarins (type Ia). Hence, an additional oxidative step as hitherto realized by treatment with DDQ was not required. Alternatively, N-alkylation of the lactone with bromoacetaldehyde dimethyl acetal followed by acid catalyzed cyclization (TfOH) of acetal 100 afforded unsaturated lamellarins in a more convenient and shorter fashion. In summary, lamellarin L (55) and N (58) were obtained in 29% and 34% over 13 steps, respectively. Alternatively, lamellarin N was obtained in 42% yield over 11 steps using the acetal based annulation route (Scheme 15).
Marinedrugs 12 06142 g016 1024
Scheme 15. Synthesis of lamellarins N and L by Iwao et al. [81].
Scheme 15. Synthesis of lamellarins N and L by Iwao et al. [81].
Marinedrugs 12 06142 g016

4. Syntheses of Type I-lamellarins—Approaches via N-Ylide-Mediated Pyrrole Ring Formation

4.1. Iwao 1997 [82]

Iwao and co-workers reported the earliest synthesis of the most cytotoxic and potent representative of the lamellarins, lamellarin D [24] as well as the fully demethylated lamellarin H by assembly of the pyrrole unit at a later stage. The required papaverine derivative 101 was obtained from O‑benzylisovanillin after a sequence of nitroaldol condensation, conjugated addition of methanol, LiAlH4-reduction, amide condensation and Bischler-Napieralski cyclization in 26% over five steps. The MOM‑protected benzoate 102 was obtained in 49% over four steps from methyl 2,4-dihydroxybenzoate by O-benzylation, bromination, Br/OMe exchange and protection with MOM-Cl.
After benzylic deprotonation with LDA, 101 was reacted with benzoate 102 and furnished ketone 103 which was subsequently N-alkylated with ethyl bromoacetate followed by closure of the pyrrole ring. Acidic removal of the MOM-group and base promoted lactonization provided the protected type Ib-lamellarin 104. The final deprotection was achieved by hydrogenolysis to provide lamellarin D (57) in 5% over 10 steps. Alternatively, complete O-deprotection was affected by BBr3 providing lamellarin H (105) in 4% over 10 steps from benzyl-protected isovanillin (Scheme 16).
Marinedrugs 12 06142 g017 1024
Scheme 16. Synthesis of lamellarins D and H by Iwao et al. [82].
Scheme 16. Synthesis of lamellarins D and H by Iwao et al. [82].
Marinedrugs 12 06142 g017

4.2. Guitián 2001 [83]

In the approach of Guitián, the pyrrole core was constructed in a [3+2]-cycloaddition of nitrone 110, obtained by a reduction/oxidation sequence from dihydropapaverine derivative 109, to arylpropiolic acid ester 108. The alkyne component 107 was synthesized starting from O-isopropylisovanillin (106) by iodination and Sonogashira coupling with TMS-acetylene. The latter compound was subjected to Baeyer-Villiger oxidation followed by hydrolysis of the resulting formate and protection as an isopropyl ether. Finally, the lithiation of the alkyne deprotected in the oxidation step and carboxylation with ethyl chloroformate provided arylpropiolate 108.
Dihydropapaverine derivative 109 was transformed into nitrone 110 by reduction with sodium borohydride followed by oxidation with disodium tungstate. [3+2]-Cycloaddition to alkyne 108 afforded the protected lamellarins. Cleavage of the isopropyl ethers with AlCl3 provided lamellarins I (111) and K (112) in 4% and 6% over nine steps, respectively (Scheme 17).
Marinedrugs 12 06142 g018 1024
Scheme 17. Synthesis of lamellarins I and K by Guitián et al. [83].
Scheme 17. Synthesis of lamellarins I and K by Guitián et al. [83].
Marinedrugs 12 06142 g018

4.3. Ruchirawat 2001 [84]

The cyclocondensation of commercially available dihydropapaverine hydrochloride 113 with phenacyl bromide 114 was utilized by Ruchirawat and co-workers in their key step to construct almost the entire lamellarin framework with the exception of the D-ring in a single operation. Vilsmeier formylation of the free position in the pyrrole ring followed by basic deprotection and manganese (IV) oxidation of the cyclic hemiacetal 117b or, alternatively, palladium-catalyzed oxidation with bromobenzene afforded lamellarin G trimethyl ether (48) in 7% or 27% over five steps starting from 2′-hydroxy-4′,5′-dimethoxyacetophenone (Scheme 18).
Marinedrugs 12 06142 g019 1024
Scheme 18. Synthesis of lamellarin G trimethyl ether by Ruchirawat et al. [84].
Scheme 18. Synthesis of lamellarin G trimethyl ether by Ruchirawat et al. [84].
Marinedrugs 12 06142 g019

4.4. Ruchirawat 2004 (lamellarin K&L) [85]-2006 (28 different lamellarins) [86]-Opatz 2008 (lamellarin G trimethyl ether & lamellarin U) [87]

The Ruchirawat-group envisioned that the pentasubstituted pyrrole moiety could also arise from a cyclocondensation of a 1-benzyl-3,4-dihydroisoquinoline (122), serving as an enamine precursor, with an α-nitrocinnamate (123) in a Grob pyrrole synthesis. Both components could easily be prepared from simple starting materials, allowing a highly modular and straightforward access to the lamellarins.
At first, Ruchirawat and co-workers reported the synthesis of lamellarin L and K employing the aforementioned strategy. Later on, the authors reported the hitherto most comprehensive synthetic work including the synthesis of 28 natural and non-natural lamellarins (125). The required dihydroisoquinolines 122 were prepared in an eight step synthesis as the longest sequence starting from vanillin, isovanillin and 2,3,4-trimethoxybenzaldehyde by O-benzylation followed by nitroaldol condensation, LiAlH4- or NaBH4-reduction to the 2-arylethylamines 120. Treatment of these intermediates with sodium nitrite produced arylacetic acids 121, the other coupling partners for preparing the intermediates 122. This was achieved by conversion into acid chlorides and subsequent amide formation with amines 120 followed by Bischler-Napieralski cyclization. The α-nitrocinnamates 123 were in turn prepared starting from protected aromatic aldehydes in a five step sequence including Baeyer-Villiger oxidation, basic hydrolysis, repeated benzylation, Vilsmeier formylation and final Knoevenagel condensation with ethyl nitroacetate. The Grob cyclization smoothly provided the highly functionalized pyrroles 124 which were transformed into the lamellarins with a saturated B subunit by hydrogenolysis and basic lactonization. An additional three step protocol comprising O-acetylation, DDQ oxidation to establish the 5,6-double bond and subsequent deacetylation was developed for the transformation of type Ia- into type Ib-lamellarins. Unfortunately, this strategy leads to inferior yields and requires more difficult workup procedures compared to the strategy of Iwao and co-workers [73]. Nonetheless, Ruchirawat’s approach permitted the straightforward synthesis of more than two dozen lamellarins, unifying an inexpensive and a labor saving method, as only two of the steps require a chromatographic purification of the reaction products (Scheme 19).
In 2008, Opatz and co-workers reported a modified version of Ruchirawat’s synthesis which emphasized the advantages of using tetrahydroisoquinoline-1-carbonitrile 126 as a key building block for the otherwise analogous route. Acid-sensitive groups could be included in the dihydroisoquinoline moiety as the harsh conditions of the Bischler-Napieralski reaction were avoided at that stage. The pivotal α-aminonitrile 126 was prepared from homoveratrylamine in three steps and 64% yield (later improved to 84%, vide infra). Its C-benzylation after deprotonation with KHMDS directly furnished the dihydroisoquinolines 131 which were then reacted with α-nitrocinnamates 123 to produce lamellarin U (132) and lamellarin G trimethyl ether (48) in 14% and 18% overall yield over nine and eight steps, respectively (Scheme 20).
Marinedrugs 12 06142 g020 1024
Scheme 19. Synthesis of natural and non-natural occurring lamellarins by Ruchirawat et al. [86].
Scheme 19. Synthesis of natural and non-natural occurring lamellarins by Ruchirawat et al. [86].
Marinedrugs 12 06142 g020
Marinedrugs 12 06142 g021 1024
Scheme 20. Synthesis of lamellarin G trimethyl ether and lamellarin U by Opatz et al. [87].
Scheme 20. Synthesis of lamellarin G trimethyl ether and lamellarin U by Opatz et al. [87].
Marinedrugs 12 06142 g021

5. Synthesis of type-I Lamellarins—Miscellaneous Approaches

5.1. Banwell 1997 [88]//Faulkner 2002 [89]//Alvarez 2003 [90]

Banwell and co-workers were first to report a convergent total synthesis of type I-lamellarins via an intramolecular [3+2] cycloaddition of an azomethine ylide derived from the tolane-linked dihydroisoquinolinium salt 140. The pivotal tolane 137 was synthesized from dibromostyrene 134 and iodide 136, both accessed from vanillin (two steps—quantitative yield) and isovanillin (two steps—93%), respectively. Styrene 134 formed the lithium acetylide upon treatment with nBuLi which was transmetallated into the alkynylzinc chloride to provide tolane 137 after Negishi cross-coupling with iodide 136. Baeyer-Villiger oxidation, basic hydrolysis and DCC-mediated condensation with iodoacetic acid provided the ester 138 which readily formed the dihydroisoquinolinium salt 140. Upon deprotonation, the 1,3-dipole underwent cyclization to triisopropyllamellarin K (141). Final cleavage with AlCl3 gave lamellarin K (112) in 58% over eight steps (Scheme 21). Along the same lines, the Banwell group reported the synthesis of lamellarin T (41%, six steps), U (132, 45%, six steps), and W (42%, seven steps), all starting from 3-isopropoxy-4-methoxybenzaldeyde, in 2012 [91].
Marinedrugs 12 06142 g022 1024
Scheme 21. Synthesis of lamellarin K by Banwell et al. [88].
Scheme 21. Synthesis of lamellarin K by Banwell et al. [88].
Marinedrugs 12 06142 g022
Faulkner and co-workers modified Banwell’s method by introducing the 5,6-double bond at a later stage, i.e., after the pyrrole forming [3+2] cycloaddition [88] Lamellarin α (149) and lamellarin H (105) were each synthesized in 17% overall yield, starting from the isopropyl ether of isovanillin (142). Treatment of lamellarin α with DMF·SO3 in a mixture of DMF/pyridine (4:1) provided lamellarin α 13,20-disulfate (68) in 83% yield. However, attempts to introduce a single sulfate group were unsuccessful (Scheme 22).
Marinedrugs 12 06142 g023 1024
Scheme 22. Synthesis of lamellarins H, α and α 13,20-disulfate by Faulkner et al. [89].
Scheme 22. Synthesis of lamellarins H, α and α 13,20-disulfate by Faulkner et al. [89].
Marinedrugs 12 06142 g023
Álvarez and co-workers developed a solid-phase supported version of Banwell’s route [88] and were able to synthesize lamellarin U (132) in 10% overall yield. Iodophenol 151 was linked to hydroxymethyl polystyrene resin by a Mitsunobu reaction and was subjected to Sonogashira cross‑coupling with acetylene 152. Lamellarin L was also obtained by an unexpected demethylation in the cleavage step and was isolated in 4% yield (Scheme 23).
Marinedrugs 12 06142 g024 1024
Scheme 23. Solid-Phase-Synthesis of lamellarin U by Álvarez et al. [90].
Scheme 23. Solid-Phase-Synthesis of lamellarin U by Álvarez et al. [90].
Marinedrugs 12 06142 g024

5.2. Steglich 1997 (lamellarin G trimethyl ether) [92]-2000 (lamellarin L) [77]-2006 (lamellarin G & K) [93]-2009 Guptón (Steglich Synthon) [94]

Steglich and co-workers reported the very first synthesis of lamellarin G trimethyl ether (48) in a short, elegant and biomimetic fashion. Thus, a symmetrical pyrrole-2,5-dicarboxylic acid 158 containing rings A, E, and F was prepared by oxidative dimerization of 3-arylpyruvic acid 155 followed by Paal-Knorr cyclization with 2-arylethylamine 157. Treatment of dicarboxylate 158 with lead (IV) acetate led to oxidative formation of the lactone ring. The B-ring was closed by an intramolecular palladium‑mediated Heck decarboxylation to afford lamellarin G trimethyl ether (48) in 33% over four steps. Until today, no shorter access to the core of the type I-lamellarins has been published (Scheme 24).
Marinedrugs 12 06142 g025 1024
Scheme 24. Synthesis of lamellarin G trimethyl ether by Steglich et al. [92].
Scheme 24. Synthesis of lamellarin G trimethyl ether by Steglich et al. [92].
Marinedrugs 12 06142 g025
For the synthesis of lamellarin L (55), the carboxylate groups on the pyrrole ring were differentiated as a methyl and ethyl ester. Selective cleavage of the methyl ester applying a suspension of sodium cyanide in 1,3-dimethyl-3,4,5,6-tetrahydropyrimidin-2(1H)-one (DMPU), leaving the ethyl ester intact, allowed the discrimination of the attachment points for rings E and F. The required starting materials were all synthesized from the appropriate 3,4-disubstituted aromatic aldehydes which provided 2-arylethylamine 162, ethyl arylpyruvate 160 and α-brominated methyl arylpyruvate 161 in 48%, 22% and 25% over three steps, respectively. Cyclization to key intermediate 163 was initiated by deprotonation of the ethyl ester with sodium hydride followed by C-alkylation with bromide 161 and condensation of in situ formed 1,4-diketone with arylethylamine 162. After the above-mentioned differentiation of the ester units, monoacid 163 was subjected to lead (IV)-induced lactonization which exlusively formed the desired regioisomer. Saponification of the ethyl ester was effected with potassium hydroxide and the palladium-mediated decarboxylative cyclization afforded the isopropyl ether of 55. Deprotection by AlCl3 gave lamellarin L (55) in 18% over nine steps (starting from O-isopropylisovanillin, Scheme 25).
Marinedrugs 12 06142 g026 1024
Scheme 25. Synthesis of lamellarin L by Steglich et al. [77].
Scheme 25. Synthesis of lamellarin L by Steglich et al. [77].
Marinedrugs 12 06142 g026
The same reaction sequence was applied to the synthesis of lamellarin G (167) and K (112) which were obtained in 27% over seven steps and 18% over nine steps, respectively. The lower yield of lamellarin K may be due to the increased sterical hindrance imposed by the additional ortho‑substituent (Scheme 26).
Marinedrugs 12 06142 g027 1024
Scheme 26. Synthesis of lamellarins G and K by Steglich et al. [93].
Scheme 26. Synthesis of lamellarins G and K by Steglich et al. [93].
Marinedrugs 12 06142 g027
Later on, Gupton and co-workers reported two new methods for the synthesis of the intermediate 158 used by the Steglich group, one being sequential and the other one being convergent. Hence, the common intermediate 158 was prepared by the sequential route in 27% over five steps (starting from already prefunctionalized 2,3,5-trisubstituted pyrrole 168) or by the convergent route in 16% over eight steps (starting from desoxyveratroin 171, Scheme 27). Gupton also developed approaches to functionalized pyrroles suitable as precursors to type-I and type-II lamellarins and most recently published a second formal total synthesis of lamellarin G trimethyl ether [95,96].
Marinedrugs 12 06142 g028 1024
Scheme 27. Synthesis of common intermediate 158 by Gupton et al. [94].
Scheme 27. Synthesis of common intermediate 158 by Gupton et al. [94].
Marinedrugs 12 06142 g028

5.3. Yadav 2009 [97]

An efficient, elegant, and very short access to lamellarin G trimethyl ether (48) was published by Yadav and co-workers. Starting with a Friedel-Crafts acylation of veratrole (175) with maleic anhydride to trans-acid 176, esterification with 3,4-dimethoxyphenol (177) and intramolecular haloarylation furnished α-bromolactone 179. A substitution reaction with 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline (180) and aerobic oxidation/deprotonation provided the azomethine ylide which underwent a cyclocondensation to the target lamellarin 48 which was obtained in 44% over four steps. The synthesis represents the first example of an early construction of subunit E and lactone-subunit D before the construction of the pyrrole moiety (Scheme 28).
Marinedrugs 12 06142 g029 1024
Scheme 28. Synthesis of lamellarin G trimethyl ether by Yadav et al. [97].
Scheme 28. Synthesis of lamellarin G trimethyl ether by Yadav et al. [97].
Marinedrugs 12 06142 g029

5.4. Jia 2011 [70]

The same biomimetic approach comprising three oxidative ring closures as used in their synthesis of lamellarin R (vide supra) was employed by Jia and co-workers for a concise route to lamellarin D and H.
Starting from O-isopropylvanillin (183) and O-isopropylisovanillin (181), O-protected 2-arylethylamine 182 and 3,4-dialkoxy-substituted phenylacetaldehyde 184 were prepared. AgOAc‑mediated oxidative coupling afforded pyrrole 185 in the key step. Vilsmeier-Haack formylation under standard conditions led to either decomposition or resulted in no conversion at all. However, microwave irradiation solved that problem and after various attempts, Pinnick/Lindgren oxidation was found to provide carboxylic acid, albeit in a low yield. Further optimization revealed that the ratio of the solvents dramatically affected the conversion and the outcome of the oxidation, indicating that THF/tBuOH/H2O (3:3:1) as the solvent system afforded carboxylic acid 186 in high yield. Oxidative lactonization according to Steglich and annulation according to Iwao followed by DDQ-mediated dehydrogenation of the B-ring provided lamellarin D (55) after BCl3-mediated deprotection in 13% over nine steps. Cleavage of all ether groups by the stronger Lewis acid BBr3 gave lamellarin H (105) in 13% over ten steps as well (Scheme 29).
Marinedrugs 12 06142 g030 1024
Scheme 29. Synthesis of lamellarins D and H by Jia et al. [70].
Scheme 29. Synthesis of lamellarins D and H by Jia et al. [70].
Marinedrugs 12 06142 g030

5.5. Opatz 2013 [16]

The so far highest yielding and fully modular total synthesis of the type I-lamellarins was recently reported by Opatz and co-workers. In a first key step, an extended von Miller-Plöchl-type reaction of a quantitatively deprotonated α-aminonitrile 190 to α,β-unsaturated aldehydes 188 provided pyrrolo[2,1-a]isoquinolines 191 in high yield (both 93%). The Michael acceptors 188 as well as the bicyclic α‑aminonitrile 190 were readily prepared from vanillin and homoveratrylamine (42). Vilsmeier formylation followed by Pinnick/Lindgren oxidation provided pyrrole carboxylic acids which were used without purification as crude DMF solutions due to their instability which was observed by Jia and Ruchirawat as well [70,85]. In contrast to Jia’s protocol, 1,4-dioxane/H2O (7:1) was used as the solvent in the oxidation step. Ullmann-like lactone formation mediated by copper thiophene-2-carboxylate (CuTC) served as the second key step and completed the lamellarin core. Lamellarin G trimethyl ether (48) was obtained in 67% over seven steps, dihydrolamellarin η (194) and lamellarin η (193) were obtained in 62% (eight steps) and 57% (nine steps), respectively, after optional dehydrogenation (DDQ) and BCl3-promoted deprotection (Scheme 30).
Marinedrugs 12 06142 g031 1024
Scheme 30. Synthesis of lamellarin G trimethyl ether, dihydrolamellarin η and lamellarin η by Opatz et al. [16].
Scheme 30. Synthesis of lamellarin G trimethyl ether, dihydrolamellarin η and lamellarin η by Opatz et al. [16].
Marinedrugs 12 06142 g031

5.6. Yamaguchi 2014 [98]

A concise synthesis of lamellarin C (201) and I (111) was recently presented by Yamaguchi and co‑workers. The first general β-selective C-H-arylation of pyrroles was combined with an intramolecular double oxidative biaryl coupling to generate the B- and the D-ring in a single operation.
Starting from 2,3,4-trimethoxybenzaldehyde (195), a sequence comprising nitroaldol condensation, LiAlH4 reduction and Paal-Knorr pyrrole synthesis was employed to obtain the N-substituted pyrrole 196. Rhodium-catalyzed arylation with iodoarenes 197 occurred exclusively at C3 and was followed by treatment with trichloroacetyl chloride. Hydrolysis and esterification of the produced carboxylic acid provided phenolic ester 200. Oxidation with palladium (II)-acetate (2 equiv.) and copper (II)-acetate (6 equiv.) furnished the pentacyclic ABCDE-framework after preparative thin layer chromatography (22 and 46% yield over 3 steps, respectively). The singly coupled side product could be isolated by gel permeability chromatography from the complex residual mixture. Global deprotection with BCl3 afforded lamellarins I (111) and C (201) in 3% over eight steps (Scheme 31).
Marinedrugs 12 06142 g032 1024
Scheme 31. Synthesis of lamellarins C and I by Yamaguchi et al. [98].
Scheme 31. Synthesis of lamellarins C and I by Yamaguchi et al. [98].
Marinedrugs 12 06142 g032

6. Conclusions

Since their discovery in 1985, the lamellarin alkaloids have attracted the attention of scientists from the areas of biochemistry, synthetic organic chemistry, pharmaceutical and medicinal chemistry as well as biology, pharmacology, and medicine. Since 1995, more than 30 syntheses of the original lamellarins have been published. If related pyrrole-derived alkaloids such as lukianol A, the polycitrins A and B, the polycitones A and B, storniamide A, the didemnimide A–C and the ningalins A–D are also taken into account, this number is easily doubled. The synthetic approaches to the lamellarins are not limited to the naturally occurring representatives but also permit the preparation of analogues. Moreover, they allow substantial amounts of the lamellarins to be made which are required for investigations of their biological properties. Some of the syntheses rely on hidden symmetry in their target and are not suitable for the preparation of the majority of the other lamellarins.
On the other hand, modular strategies were reported which build up the lamellarin scaffold from commercial or readily available simple starting materials. A major class of syntheses employs a cyclocondensation or a cycloaddition reaction to establish the pyrrole core from precursors already carrying the alkoxylated benzene units later to become rings A, E, and F. In a second large class of syntheses, a simple pyrrole derivative is sequentially decorated with the required aryl moieties, mostly using halogenation/cross-coupling methodology.
The most prominent advantage of the cross-coupling based strategies is the possibility to generate a multitude of substitution patterns from libraries of differentially protected or O-methylated 3,4-dihydroxyphenylboronic acids in a combinatorial fashion. On the other hand, cyclocondensation or cycloaddition based strategies allow the construction of the entire lamellarin framework from prefunctionalized precursors under avoidance of yield-diminishing long linear reaction sequences. Thus, it is not surprising that the most efficient routes belong to the latter category. A comparison of the reported syntheses of the type-I lamellarins can be found in Table 1.
Table
Table 1. Comparison of completed total syntheses of the type-I lamellarins.
Table 1. Comparison of completed total syntheses of the type-I lamellarins.
Lead AuthorYearLamellarinOverall YieldLinear StepsStarting from
Steglich1997G trimethyl ether33%43-(3,4-Dimethoxyphenyl)pyruvic acid
Banwell1997K58%74-Isopropoxy-3-methoxybenzaldehyde
Iwao1997H4%103-Benzyloxy-4-methoxybenzaldehyde
D5%103-Benzyloxy-4-methoxybenzaldehyde
Steglich2000L18%93-Isopropoxy-4-methoxybenzaldeyde
Guitián2001I4%93-Isopropoxy-4-methoxybenzaldeyde
K6%93-Isopropoxy-4-methoxybenzaldeyde
Ruchirawat2001G trimethyl ether27%52‘-Hydroxy-4′,5′-dimethoxyacetophenone
Faulkner2002H17%93-Isopropoxy-4-methoxybenzaldehyde
α17%93-Isopropoxy-4-methoxybenzaldehyde
α 13,20-disulfate14%103-Isopropoxy-4-methoxybenzaldehyde
Iwao2003G trimethyl ether12%9Homoveratrylamine
Handy2004G trimethyl ether10%8Ethyl 4-bromopyrrole-2-carboxylate
Álvarez2005D3%163-Isopropoxy-4-methoxybenzaldehyde
Iwao2006N16%123-Isopropoxy-4-methoxybenzaldeyde
D18%123-Isopropoxy-4-methoxybenzaldeyde
L19%113-Isopropoxy-4-methoxybenzaldeyde
2006α 20-sulfate24%14Homoveratrylamine
Steglich2006K18%94-Bromo-2,3-dimethoxybenzaldehyde
G27%73-Isopropoxy-4-methoxybenzaldeyde
Ruchirawat2006I, C, T, F, K, E, dihydro‑η, G trimethyl ether, J, U, L, G, χ, Y ξ, B, W, ε, M, X, η, J‑DB, α, N, G‑DB, D, Y‑DB5%–34% (saturated)
4%–30% (unsaturated)		8–9 (saturated)
11–12 (unsaturated)		3-Benzyloxy-4-methoxybenzaldehyde
4-Benzyloxy-3-methoxybenzaldehyde
Veratraldehyde
2,3,4-Trimethoxybenzaldehyde
2,4-Dibenzyloxy-5-methoxybenzaldehyde
2,5-Dibenzyloxy-4-methoxybenzaldehyde
2-Benzyloxy-4,5-dimethoxybenzaldehyde
Opatz2008U14%93-Benzyloxy-4-methoxybenzaldehyde
G trimethyl ether18%8Veratraldehyde
Yadav2009G trimethyl ether44%4Veratrole
Iwao2010α 20-sulfate6%153-Isopropoxy-4-methoxybenzaldeyde
α 13-sulfate4%153-Isopropoxy-4-methoxybenzaldeyde
α 13,20-disulfate9%143-Isopropoxy-4-methoxybenzaldeyde
Banwell2011G trimethyl ether3%10N-Boc-pyrrole
S7%113,4-Diisopropoxybenzaldehyde
Jia2011D13%94-Isopropoxy-3-methoxybenzaldehyde
H13%94-Isopropoxy-3-methoxybenzaldehyde
Banwell2012T41%63-Isopropoxy-4-methoxybenzaldeyde
W42%73-Isopropoxy-4-methoxybenzaldeyde
U45%63-Isopropoxy-4-methoxybenzaldeyde
Opatz2013η57%94-Benzyloxy-3-methoxyphenylacetonitrile
dihydro-η62%84-Benzyloxy-3-methoxyphenylacetonitrile
G trimethyl ether69%73,4-Dimethoxyphenylacetonitrile
Iwao2014L30%13N-Boc-2,5-dibromopyrrole
N42%11N-Boc-2,5-dibromopyrrole
Yamaguchi2014C3%82,3,4-Trimethoxybenzaldehyde
I3%82,3,4-Trimethoxybenzaldehyde
The steps in the longest linear sequence were counted from the O-protected building blocks as the majority of the authors used this definition.
In the history of lamellarin synthesis, around 20 more or less different strategies have been devised until today. They exhibit a significant span of overall yields as well as the numbers of steps in the longest linear sequence but clearly, a decision on the suitability of an approach for solving a given synthetic problem also has to take into account the availability and price of the starting materials as well as the catalysts and reagents involved, let alone ecological issues which may become key factors in large-scale synthesis.
Due to the considerable attractivity of the lamellarin alkaloids, both from a biomedical and from a synthetic perspective, new approaches will continue to be developed. They will contribute to a better understanding of the chemistry as well as the biological activity of this compound class and may allow the rational design and preparation of more potent and/or more selective derivatives for prospective medicinal and pharmacological research.

Acknowledgments

J.T. is grateful to the Fonds der Chemischen Industrie for a PhD-fellowship. We thank the Rhineland Palatinate Center for Natural Product Research for helpful discussions.

Author Contributions

This review was conceived, designed, written and polished by Dennis Imbri, Johannes Tauber and Till Opatz. All authors discussed the content of the review.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Andersen, R.J.; Faulkner, D.J.; He, C.H.; Van Duyne, G.D.; Clardy, J. Metabolites of the marine prosobranch mollusk Lamellaria sp. J. Am. Chem. Soc. 1985, 107, 5492–5495. [Google Scholar] [CrossRef]
  2. Lindquist, N.; Fenical, W.; van Duyne, G.D.; Clardy, J. New alkaloids of the lamellarin class from the marine ascidian Didemnum chartaceum. J. Org. Chem. 1988, 53, 4570–4574. [Google Scholar] [CrossRef]
  3. Carroll, A.R.; Bowden, B.F.; Coll, J.C. Studies of Australian ascidians. I. Six new lamellarin-class alkaloids from a colonial ascidian, Didemnum sp. Aust. J. Chem. 1993, 46, 489–501. [Google Scholar] [CrossRef]
  4. Urban, S.; Butler, M.S.; Capon, R.J. Lamellarins O and P: New aromatic metabolites from the Australian marine sponge Dendrilla cactos. Aust. J. Chem. 1994, 47, 1919–1924. [Google Scholar] [CrossRef]
  5. Urban, S.; Hobbs, L.; Hooper, J.N.A.; Capon, R.J. Lamellarins Q and R: New aromatic metabolites from an Australian marine sponge, Dendrilla cactos. Aust. J. Chem. 1995, 48, 1491–1494. [Google Scholar] [CrossRef]
  6. Urban, S.; Capon, R.J. Lamellarin-s: A new aromatic metabolite from an Australian tunicate, Didemnum sp. Aust. J. Chem. 1996, 49, 711–713. [Google Scholar]
  7. Reddy, M.V.R.; Faulkner, D.J.; Venkateswarlu, Y.; Rao, M.R. New lamellarin alkaloids from an unidentified ascidian from the Arabian Sea. Tetrahedron 1997, 53, 3457–3466. [Google Scholar] [CrossRef]
  8. Davis, R.A.; Carroll, A.R.; Pierens, G.K.; Quinn, R.J. New lamellarin alkaloids from the Australian ascidian, Didemnum chartaceum. J. Nat. Prod. 1999, 62, 419–424. [Google Scholar] [CrossRef] [PubMed]
  9. Ham, J.; Kang, H. A novel cytotoxic alkaloid of lamellarin class from a marine ascidian Didemnum sp. Bull. Korean Chem. Soc. 2002, 23, 163–166. [Google Scholar] [CrossRef]
  10. Krishnaiah, P.; Reddy, V.L.N.; Venkataramana, G.; Ravinder, K.; Srinivasulu, M.; Raju, T.V.; Ravikumar, K.; Chandrasekar, D.; Ramakrishna, S.; Venkateswarlu, Y. New lamellarin alkaloids from the Indian ascidian Didemnum obscurum and their antioxidant properties. J. Nat. Prod. 2004, 67, 1168–1171. [Google Scholar] [CrossRef] [PubMed]
  11. Reddy, S.M.; Srinivasulu, M.; Satyanarayana, N.; Kondapi, A.K.; Venkateswarlu, Y. New potent cytotoxic lamellarin alkaloids from Indian ascidian Didemnum obscurum. Tetrahedron 2005, 61, 9242–9247. [Google Scholar] [CrossRef]
  12. Koeck, M.; Reif, B.; Fenical, W.; Griesinger, C. Differentiation of HMBC two- and three-bond correlations: A method to simplify the structure determination of natural products. Tetrahedron Lett. 1996, 37, 363–366. [Google Scholar] [CrossRef]
  13. Reif, B.; Kock, M.; Kerssebaum, R.; Kang, H.; Fenical, W.; Griesinger, C. Adequate, a new set of experiments to determine the constitution of small molecules at natural abundance. J. Magn. Reson. Ser. A 1996, 118, 282–285. [Google Scholar] [CrossRef]
  14. Reif, B.; Koeck, M.; Kerssebaum, R.; Schleucher, J.; Griesinger, C. Determination of 1J, 2J, and 3J carbon-carbon coupling constants at natural abundance. J. Magn. Reson. Ser. B 1996, 112, 295–301. [Google Scholar] [CrossRef]
  15. Fukuda, T.; Itoyama, R.; Minagawa, T.; Iwao, M. Rotational energy barrier around the C1-C11 single bond in lamellarins: A study by variable-temperature NMR. Heterocycles 2014, 88, 1121–1133. [Google Scholar] [CrossRef]
  16. Imbri, D.; Tauber, J.; Opatz, T. A high-yielding modular access to the lamellarins: Synthesis of lamellarin G trimethyl ether, lamellarin η and dihydrolamellarin η. Chem. Eur. J. 2013, 19, 15080–15083. [Google Scholar] [CrossRef] [PubMed]
  17. Quesada, A.R.; Gravalos, M.D.G.; Puentes, J.L.F. Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein. Br. J. Cancer 1996, 74, 677–682. [Google Scholar] [CrossRef] [PubMed]
  18. Burnham, B.S.; Gupton, J.T.; Krumpe, K.; Webb, T.; Shuford, J.; Bowers, B.; Warren, A.E.; Barnes, C.; Hall, I.H. Cytotoxicity of substituted alkyl-3,4-bis(4-methoxyphenyl)pyrrole-2-carboxylates in L1210 lymphoid leukemia cells. Arch. Pharm. 1998, 331, 337–341. [Google Scholar] [CrossRef]
  19. Reddy, M.V.R.; Rao, M.R.; Rhodes, D.; Hansen, M.S.T.; Rubins, K.; Bushman, F.D.; Venkateswarlu, Y.; Faulkner, D.J. Lamellarin α 20-sulfate, an inhibitor of HIV-1 integrase active against HIV-1 virus in cell culture. J. Med. Chem. 1999, 42, 1901–1907. [Google Scholar] [CrossRef] [PubMed]
  20. Liu, R.; Liu, Y.; Zhou, Y.-D.; Nagle, D.G. Molecular-targeted antitumor agents: Neolamellarins from the marine sponge Dendrilla nigra inhibit hypoxia-inducible factor-1 activation and secreted vascular endothelial growth factor production in breast tumor cells. J. Nat. Prod. 2007, 70, 1741–1745. [Google Scholar] [CrossRef] [PubMed]
  21. Baunbaek, D.; Trinkler, N.; Ferandin, Y.; Lozach, O.; Ploypradith, P.; Rucirawat, S.; Ishibashi, F.; Iwao, M.; Meijer, L. Anticancer alkaloid lamellarins inhibit protein kinases. Mar. Drugs 2008, 6, 514–527. [Google Scholar] [CrossRef] [PubMed]
  22. Gallego, M.A.; Ballot, C.; Kluza, J.; Hajji, N.; Martoriati, A.; Castera, L.; Cuevas, C.; Formstecher, P.; Joseph, B.; Kroemer, G.; et al. Overcoming chemoresistance of non-small cell lung carcinoma through restoration of an AIF-dependent apoptotic pathway. Oncogene 2008, 27, 1981–1992. [Google Scholar] [CrossRef] [PubMed]
  23. Huang, X.-C.; Xiao, X.; Salim, A.A.; Capon, R.J.; Zhang, Y.-K.; Talele, T.T.; Chen, Z.-S. Lamellarin O, a pyrrole alkaloid from an Australian marine sponge, Ianthella sp., reverses BCRP‑mediated drug resistance in cancer cells. Mar. Drugs 2014, 12, 3818–3837. [Google Scholar] [CrossRef] [PubMed]
  24. Vanhuyse, M.; Kluza, J.; Tardy, C.; Otero, G.; Cuevas, C.; Bailly, C.; Lansiaux, A. Lamellarin D: A novel pro-apoptotic agent from marine origin insensitive to P-glycoprotein-mediated drug efflux. Cancer Lett. 2005, 221, 165–175. [Google Scholar] [CrossRef] [PubMed]
  25. Kluza, J.; Gallego, M.-A.; Loyens, A.; Beauvillain, J.-C.; Fernandez Sousa-Faro, J.-M.; Cuevas, C.; Marchetti, P.; Bailly, C. Cancer cell mitochondria are direct proapoptotic targets for the marine antitumor drug lamellarin D. Cancer Res. 2006, 66, 3177–3187. [Google Scholar] [CrossRef] [PubMed]
  26. Ballot, C.; Kluza, J.; Martoriati, A.; Nyman, U.; Formstecher, P.; Joseph, B.; Bailly, C.; Marchetti, P. Essential role of mitochondria in apoptosis of cancer cells induced by the marine alkaloid lamellarin D. Mol. Cancer Ther. 2009, 8, 3307–3317. [Google Scholar] [CrossRef] [PubMed]
  27. Ballot, C.; Kluza, J.; Lancel, S.; Martoriati, A.; Hassoun, S.M.; Mortier, L.; Vienne, J.-C.; Briand, G.; Formstecher, P.; Bailly, C.; et al. Inhibition of mitochondrial respiration mediates apoptosis induced by the anti-tumoral alkaloid lamellarin D. Apoptosis 2010, 15, 769–781. [Google Scholar] [CrossRef] [PubMed]
  28. Khiati, S.; Seol, Y.; Agama, K.; Dalla Rosa, I.; Agrawal, S.; Fesen, K.; Zhang, H.; Neuman, K.C.; Pommie, Y. Poisoning of mitochondrial topoisomerase I by lamellarin D. Mol. Pharmacol. 2014, 86, 193–199. [Google Scholar] [CrossRef] [PubMed]
  29. Facompre, M.; Tardy, C.; Bal-Mahieu, C.; Colson, P.; Perez, C.; Manzanares, I.; Cuevas, C.; Bailly, C. Lamellarin D: A novel potent inhibitor of topoisomerase I. Cancer Res. 2003, 63, 7392–7399. [Google Scholar] [PubMed]
  30. Tardy, C.; Facompre, M.; Laine, W.; Baldeyrou, B.; Garcia-Gravalos, D.; Francesch, A.; Mateo, C.; Pastor, A.; Jimenez, J.A.; Manzanares, I.; et al. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: Triester derivatives incorporating amino acid residues. Bioorg. Med. Chem. 2004, 12, 1697–1712. [Google Scholar] [CrossRef] [PubMed]
  31. Marco, E.; Laine, W.; Tardy, C.; Lansiaux, A.; Iwao, M.; Ishibashi, F.; Bailly, C.; Gago, F. Molecular determinants of topoisomerase I poisoning by lamellarins: Comparison with camptothecin and structure-activity relationships. J. Med. Chem. 2005, 48, 3796–3807. [Google Scholar] [CrossRef] [PubMed]
  32. Chittchang, M.; Batsomboon, P.; Ruchirawat, S.; Ploypradith, P. Cytotoxicities and structure-activity relationships of natural and unnatural lamellarins toward cancer cell lines. ChemMedChem 2009, 4, 457–465. [Google Scholar] [CrossRef] [PubMed]
  33. Pla, D.; Sischka, A.; Albericio, F.; Alvarez, M.; Fernandez-Busquets, X.; Anselmetti, D. Optical-tweezers study of topoisomerase inhibition. Small 2009, 5, 1269–1272. [Google Scholar] [CrossRef] [PubMed]
  34. Bayet-Robert, M.; Lim, S.; Barthomeuf, C.; Morvan, D. Biochemical disorders induced by cytotoxic marine natural products in breast cancer cells as revealed by proton NMR spectroscopy-based metabolomics. Biochem. Pharmacol. 2010, 80, 1170–1179. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Khadka, D.B.; Cho, W.-J. Topoisomerase inhibitors as anticancer agents: A patent update. Expert Opin. Ther. Pat. 2013, 23, 1033–1056. [Google Scholar] [CrossRef] [PubMed]
  36. Ballot, C.; Martoriati, A.; Jendoubi, M.; Buche, S.; Formstecher, P.; Mortier, L.; Kluza, J.; Marchetti, P. Another facet to the anticancer response to lamellarin D: Induction of cellular senescence through inhibition of topoisomerase I and intracellular ROS production. Mar. Drugs 2014, 12, 779–798. [Google Scholar] [CrossRef] [PubMed]
  37. Pungkham, H.; Swatdipakdi, N.; Theerasilp, M.; Karnkla, S.; Chittchang, M.; Ploypradith, P.; Nasongkla, N. PEG-b-PCL and PEG-b-PLA polymeric micelles as nanocarrieres for lamellarin N delivery. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2011, 2011, 3245–3248. [Google Scholar] [PubMed]
  38. Chittchang, M.; Paul Gleeson, M.; Ploypradith, P.; Ruchirawat, S. Assessing the drug-likeness of lamellarins, a marine-derived natural product class with diverse oncological activities. Eur. J. Med. Chem. 2010, 45, 2165–2172. [Google Scholar] [CrossRef] [PubMed]
  39. Thipnate, P.; Chittchang, M.; Thasana, N.; Saparpakorn, P.; Ploypradith, P.; Hannongbua, S. Exploring the molecular basis for selective cytotoxicity of lamellarins against human hormone-dependent T47D and hormone-independent MDA-MB-231 breast cancer cells. Monatsh. Chem. 2011, 142, 97–109. [Google Scholar] [CrossRef]
  40. Plisson, F.; Conte, M.; Khalil, Z.; Huang, X.-C.; Piggott, A.M.; Capon, R.J. Kinase inhibitor scaffolds against neurodegenerative diseases from a southern Australian ascidian, Didemnum sp. ChemMedChem 2012, 7, 983–990. [Google Scholar] [CrossRef] [PubMed]
  41. Davis, R.A.; Vullo, D.; Maresca, A.; Supuran, C.T.; Poulsen, S.-A. Natural product coumarins that inhibit human carbonic anhydrases. Bioorg. Med. Chem. 2013, 21, 1539–1543. [Google Scholar] [CrossRef] [PubMed]
  42. Bailly, C. Lamellarins, from A to Z: A family of anticancer marine pyrrole alkaloids. Curr. Med. Chem. Anti-Cancer Agents 2004, 4, 363–378. [Google Scholar] [CrossRef]
  43. Cironi, P.; Albericio, F.; Alvarez, M. Lamellarins: Isolation, activity and synthesis. Prog. Heterocycl. Chem. 2004, 16, 1–26. [Google Scholar]
  44. Handy, S.T.; Zhang, Y. Approaches to the synthesis of the lamellarins and related natural products. A review. Org. Prep. Proced. Int. 2005, 37, 411–445. [Google Scholar] [CrossRef]
  45. Yang, G.; Wang, A.-L.; Chen, H.-L.; You, Y.-C. Recent research progresses on lamellarins and analogous alkaloids of bioactive marine mollusc. Chin. J. Org. Chem. 2005, 25, 641–653. (In Chinese) [Google Scholar]
  46. He, Y.-R.; Li, D.-P.; Yang, G.; Wang, A.-L.; You, Y.-C.; Hu, D.-H.; Yu, X.-S. Recent research progress on biological activity of lamellarins and analogous alkaloids. Chin. J. Nat. Med. 2007, 5, 150–156. (In Chinese) [Google Scholar]
  47. Fan, H.; Peng, J.; Hamann, M.T.; Hu, J.-F. Lamellarins and related pyrrole-derived alkaloids from marine organisms. Chem. Rev. 2008, 108, 264–287. [Google Scholar] [CrossRef] [PubMed]
  48. Pla, D.; Albericio, F.; Alvarez, M. Recent advances in lamellarin alkaloids: Isolation, synthesis and activity. Anti-Cancer Agents Med. Chem. 2008, 8, 746–760. [Google Scholar] [CrossRef]
  49. You, Y.-C.; Hu, D.-H.; Li, D.-P.; Wang, A.-L.; Yu, X.-S. Recent research progress in lamellarin D and its derivatives. Chin. J. Org. Chem. 2008, 28, 797–803. (In Chinese) [Google Scholar]
  50. Shen, L.; Hu, Y. Recent advances in the synthesis of lamellarins as anticancer alkaloids. Chin. J. Org. Chem. 2009, 29, 867–875. (In Chinese) [Google Scholar]
  51. Fan, A.-L.; Lin, W.-H.; Jia, Y.-X. Recent progress in the research on lamellarins and related pyrrole-derived alkaloids from marine organisms. J. Chin. Pharm. Sci. 2011, 20, 425–441. (In Chinese) [Google Scholar]
  52. Fukuda, T.; Ishibashi, F.; Iwao, M. Synthesis and biological activity of lamellarin alkaloids. Heterocycles 2011, 83, 491–529. [Google Scholar] [CrossRef]
  53. Liao, S.; Li, D.; Liu, R.; Wang, A. Research progress in lamellarin H. Chem. Res. Appl. 2011, 23, 961–966. (In Chinese) [Google Scholar]
  54. Pla, D.; Albericio, F.; Alvarez, M. Progress on lamellarins. Med. Chem. Commun. 2011, 2, 689–697. [Google Scholar] [CrossRef] [Green Version]
  55. Wang, A.; Zhao, Z.; Zheng, X.; Cao, H. Recent research progress in anticancer alkaloid lamellarin N and lamellarin L. Chin. J. Org. Chem. 2013, 33, 483–491. (In Chinese) [Google Scholar] [CrossRef]
  56. Urban, S.; Hickford, S.J.H.; Blunt, J.W.; Munro, M.H.G. Bioactive marine alkaloids. Curr. Org. Chem. 2000, 4, 765–807. [Google Scholar] [CrossRef]
  57. Fernandez, D.; Ahaidar, A.; Danelon, G.; Cironi, P.; Marfil, M.; Perez, O.; Cuevas, C.; Albericio, F.; Joule, J.A.; Alvarez, M. Synthesis of polyheterocyclic nitrogen-containing marine natural products. Monatsh. Chem. 2004, 135, 615–627. [Google Scholar] [CrossRef]
  58. Dias, N.; Vezin, H.; Lansiaux, H.; Lansiaux, A.; Bailly, C. Topoisomerase inhibitors of marine origin and their potential use as anticancer agents. Top. Curr. Chem. 2005, 253, 89–108. [Google Scholar]
  59. Wang, W.; Namikoshi, M. Bioactive nitrogenous metabolites from ascidians. Heterocycles 2007, 74, 53–88. [Google Scholar] [CrossRef]
  60. Barthomeuf, C.; Bourguet-Kondracki, M.-L.; Kornprobst, J.-M. Marine metabolites overcoming or circumventing multidrug resistance mediated by ATP-dependent transporters: A new hope for patient with tumors resistant to conventional chemotherapy. Anti-Cancer Agents Med. Chem. 2008, 8, 886–903. [Google Scholar] [CrossRef]
  61. Gong, W.; Li, L.; Yi, Y.; Zhang, D. Research progress in the studies on the synthesis of marine alkaloids. Chin. Pharm. J. 2008, 26, 327–333. (In Chinese) [Google Scholar]
  62. Elyashberg, M.; Williams, A.J.; Blinov, K. Structural revisions of natural products by computer-assisted structure elucidation (CASE) systems. Nat. Prod. Rep. 2010, 27, 1296–1328. [Google Scholar] [CrossRef] [PubMed]
  63. Menna, M.; Fattorusso, E.; Imperatore, C. Alkaloids from marine ascidians. Molecules 2011, 16, 8694–8732. [Google Scholar] [CrossRef] [Green Version]
  64. Menna, M. Important classes of bioactive alkaloids from marine ascidians: Structures, isolation and bioactivity. Curr. Top. Med. Chem. 2014, 14, 207–223. [Google Scholar] [CrossRef] [PubMed]
  65. Fuerstner, A.; Weintritt, H.; Hupperts, A. A new, titanium-mediated approach to pyrroles: First synthesis of lukianol A and lamellarin O dimethyl ether. J. Org. Chem. 1995, 60, 6637–6641. [Google Scholar] [CrossRef]
  66. Banwell, M.G.; Flynn, B.L.; Hamel, E.; Hockless, D.C.R. Convergent syntheses of the pyrrolic marine natural products lamellarin O, lamellarin Q, lukianol A and some more highly oxygenated congeners. Chem. Commun. 1997, 2, 207–208. [Google Scholar] [CrossRef]
  67. Boger, D.L.; Boyce, C.W.; Labroli, M.A.; Sehon, C.A.; Jin, Q. Total syntheses of ningalin A, lamellarin O, lukianol A, and permethyl storniamide A utilizing heterocyclic azadiene diels-alder reactions. J. Am. Chem. Soc. 1999, 121, 54–62. [Google Scholar] [CrossRef]
  68. Marfil, M.; Albericio, F.; Alvarez, M. Solid-phase synthesis of lamellarins Q and O. Tetrahedron 2004, 60, 8659–8668. [Google Scholar] [CrossRef]
  69. Fukuda, T.; Sudo, E.-I.; Shimokawa, K.; Iwao, M. Palladium-catalyzed cross-coupling of N-benzenesulfonyl-3,4-dibromopyrrole and its application to the total syntheses of lamellarins O, P, Q and R. Tetrahedron 2008, 64, 328–338. [Google Scholar] [CrossRef]
  70. Li, Q.; Jiang, J.; Fan, A.; Cui, Y.; Jia, Y. Total synthesis of lamellarins D, H, and R and ningalin B. Org. Lett. 2011, 13, 312–315. [Google Scholar] [CrossRef] [PubMed]
  71. Ramirez-Rodriguez, A.; Mendez, J.M.; Jimenez, C.C.; Leon, F.; Vazquez, A. A Paal-Knorr approach to 3,4-diaryl-substituted pyrroles: Facile synthesis of lamellarins O and Q. Synthesis 2012, 44, 3321–3326. [Google Scholar] [CrossRef]
  72. Iwao, M.; Takeuchi, T.; Fujikawa, N.; Fukuda, T.; Ishibashi, F. Short and flexible route to 3,4-diarylpyrrole marine alkaloids: Syntheses of permethyl storniamide A, ningalin B, and lamellarin G trimethyl ether. Tetrahedron Lett. 2003, 44, 4443–4446. [Google Scholar] [CrossRef]
  73. Fujikawa, N.; Ohta, T.; Yamaguchi, T.; Fukuda, T.; Ishibashi, F.; Iwao, M. Total synthesis of lamellarins D, L, and N. Tetrahedron 2006, 62, 594–604. [Google Scholar] [CrossRef]
  74. Yamaguchi, T.; Fukuda, T.; Ishibashi, F.; Iwao, M. The first total synthesis of lamellarin α 20‑sulfate, a selective inhibitor of HIV-1 integrase. Tetrahedron Lett. 2006, 47, 3755–3757. [Google Scholar] [CrossRef]
  75. Fukuda, T.; Ohta, T.; Saeki, S.; Iwao, M. Divergent synthesis of lamellarin α 13-sulfate, 20-sulfate, and 13,20-disulfate. Heterocycles 2010, 80, 841–846. [Google Scholar] [CrossRef]
  76. Takada, T.; Arisawa, M.; Gyoten, M.; Hamada, R.; Tohma, H.; Kita, Y. Oxidative biaryl coupling reaction of phenol ether derivatives using a hypervalent iodine(III) reagent. J. Org. Chem. 1998, 63, 7698–7706. [Google Scholar] [CrossRef]
  77. Peschko, C.; Winklhofer, C.; Steglich, W. Alkaloids from marine organisms, part 5: Biomimetic total synthesis of lamellarin L by coupling of two different arylpyruvic acid units. Chem. Eur. J. 2000, 6, 1147–1152. [Google Scholar] [CrossRef] [PubMed]
  78. Handy, S.T.; Zhang, Y.; Bregman, H. A modular synthesis of the lamellarins: Total synthesis of lamellarin G trimethyl ether. J. Org. Chem. 2004, 69, 2362–2366. [Google Scholar] [CrossRef] [PubMed]
  79. Pla, D.; Marchal, A.; Olsen, C.A.; Albericio, F.; Alvarez, M. Modular total synthesis of lamellarin D. J. Org. Chem. 2005, 70, 8231–8234. [Google Scholar] [CrossRef] [PubMed]
  80. Hasse, K.; Willis, A.C.; Banwell, M.G. Modular total syntheses of lamellarin G trimethyl ether and lamellarin S. Eur. J. Org. Chem. 2011, 88–99. [Google Scholar]
  81. Komatsubara, M.; Umeki, T.; Fukuda, T.; Iwao, M. Modular synthesis of lamellarins via regioselective assembly of 3,4,5-differentially arylated pyrrole-2-carboxylates. J. Org. Chem. 2014, 79, 529–537. [Google Scholar] [CrossRef] [PubMed]
  82. Ishibashi, F.; Miyazaki, Y.; Iwao, M. Total syntheses of lamellarin D and H. The first synthesis of lamellarin-class marine alkaloids. Tetrahedron 1997, 53, 5951–5962. [Google Scholar] [CrossRef]
  83. Diaz, M.; Guitian, E.; Castedo, L. Syntheses of lamellarins I and K by [3+2] cycloaddition of a nitrone to an alkyne. Synlett 2001, 1164–1166. [Google Scholar]
  84. Ruchirawat, S.; Mutarapat, T. An efficient synthesis of lamellarin alkaloids: Synthesis of lamellarin G trimethyl ether. Tetrahedron Lett. 2001, 42, 1205–1208. [Google Scholar] [CrossRef]
  85. Ploypradith, P.; Mahidol, C.; Sahakitpichan, P.; Wongbundit, S.; Ruchirawat, S. A highly efficient synthesis of lamellarins K and L by the Michael addition/ring-closure reaction of benzyldihydroisoquinoline derivatives with ethoxycarbonyl-β-nitrostyrenes. Angew. Chem. Int. Ed. 2004, 43, 866–868. [Google Scholar] [CrossRef]
  86. Ploypradith, P.; Petchmanee, T.; Sahakitpichan, P.; Litvinas, N.D.; Ruchirawat, S. Total synthesis of natural and unnatural lamellarins with saturated and unsaturated D-rings. J. Org. Chem. 2006, 71, 9440–9448. [Google Scholar] [CrossRef] [PubMed]
  87. Liermann, J.C.; Opatz, T. Synthesis of lamellarin U and lamellarin G trimethyl ether by alkylation of a deprotonated α-aminonitrile. J. Org. Chem. 2008, 73, 4526–4531. [Google Scholar] [CrossRef] [PubMed]
  88. Banwell, M.G.; Flynn, B.L.; Hockless, D.C.R. Convergent total synthesis of lamellarin K. Chem. Commun. 1997, 23, 2259–2260. [Google Scholar] [CrossRef]
  89. Ridley, C.P.; Reddy, M.V.R.; Rocha, G.; Bushman, F.D.; Faulkner, D.J. Total synthesis and evaluation of lamellarin α 20-sulfate analogues. Bioorg. Med. Chem. 2002, 10, 3285–3290. [Google Scholar] [CrossRef] [PubMed]
  90. Cironi, P.; Manzanares, I.; Albericio, F.; Alvarez, M. Solid-phase total synthesis of the pentacyclic system lamellarins U and L. Org. Lett. 2003, 5, 2959–2962. [Google Scholar] [CrossRef] [PubMed]
  91. Flynn, B.L.; Banwell, M.G. Convergent total syntheses of the pentacyclic lamellarins K, T, U and W via the addition of azomethine ylides to tethered tolans. Heterocycles 2012, 84, 1141–1170. [Google Scholar] [CrossRef]
  92. Heim, A.; Terpin, A.; Steglich, W. Alkaloids from marine organisms. 2. Biomimetic synthesis of lamellarin G trimethyl ether. Angew. Chem. Int. Ed. 1997, 36, 155–156. [Google Scholar] [CrossRef]
  93. Peschko, C.; Winklhofer, C.; Terpin, A.; Steglich, W. Biomimetic syntheses of lamellarin and lukianol-type alkaloids. Synthesis 2006, 18, 3048–3057. [Google Scholar]
  94. Gupton, J.T.; Giglio, B.C.; Eaton, J.E.; Rieck, E.A.; Smith, K.L.; Keough, M.J.; Barelli, P.J.; Firich, L.T.; Hempel, J.E.; Smith, T.M.; et al. The application of vinylogous iminium salt derivatives to efficient formal syntheses of the marine alkaloids lamellarin G trimethyl ether and ningalin B. Tetrahedron 2009, 65, 4283–4292. [Google Scholar] [CrossRef] [PubMed]
  95. Gupton, J.T.; Krumpe, K.E.; Burnham, B.S.; Webb, T.M.; Shuford, J.S.; Sikorski, J.A. The application of vinylogous iminium salt derivatives to a regiocontrolled and efficient relay synthesis of lukianol A and related marine natural products. Tetrahedron 1999, 55, 14515–14522. [Google Scholar] [CrossRef]
  96. Gupton, J.T.; Telang, N.; Patteson, J.; Lescalleet, K.; Yeudall, S.; Sobieski, J.; Harrison, A.; Curry, W. The application of formyl group activation of bromopyrrole esters to formal syntheses of lycogarubin C, permethyl storniamide A and lamellarin G trimethyl ether. Tetrahedron 2014, 70, 9759–9767. [Google Scholar] [CrossRef]
  97. Yadav, J.S.; Gayathri, K.U.; Reddy, B.V.S.; Prasad, A.R. Modular total synthesis of lamellarin G trimethyl ether. Synlett 2009, 1, 43–46. [Google Scholar] [CrossRef]
  98. Ueda, K.; Amaike, K.; Maceiczyk, R.M.; Itami, K.; Yamaguchi, J. β-selective C-H arylation of pyrroles leading to concise syntheses of lamellarins C and I. J. Am. Chem. Soc. 2014, 136, 13226–13232. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Imbri, D.; Tauber, J.; Opatz, T. Synthetic Approaches to the Lamellarins—A Comprehensive Review. Mar. Drugs 2014, 12, 6142-6177. https://doi.org/10.3390/md12126142

AMA Style

Imbri D, Tauber J, Opatz T. Synthetic Approaches to the Lamellarins—A Comprehensive Review. Marine Drugs. 2014; 12(12):6142-6177. https://doi.org/10.3390/md12126142

Chicago/Turabian Style

Imbri, Dennis, Johannes Tauber, and Till Opatz. 2014. "Synthetic Approaches to the Lamellarins—A Comprehensive Review" Marine Drugs 12, no. 12: 6142-6177. https://doi.org/10.3390/md12126142

Article Metrics

Back to TopTop